Table 2 Reproductive risk factors for TVUS diagnosed UF, Nigeria, 2021.
TVUS diagnosis of uterine fibroid | ||||
|---|---|---|---|---|
Negative | Positive | Total | p-value | |
(N = 266) | (N = 218) | (N = 484) | ||
Mean (SD) N (%) | Mean (SD) N (%) | Mean (SD) N (%) | ||
Age at menarche (years) | 14.3 (1.97) | 14.3 (1.93) | 14.3 (1.95) | 0.97 |
Age at menarche categories | ||||
8–14 | 148 (55.8%) | 124 (57.4%) | 272 (56.5%) | 0.91 |
15–19 | 111 (41.9%) | 88 (40.7%) | 199 (41.4%) | |
20–24 | 6 (2.3%) | 4 (1.9%) | 10 (2.1%) | |
Age at sexual debut | 19.8 (3.87) | 20.1 (3.95) | 19.9 (3.90) | 0.38 |
Age at sexual debut categories | ||||
Less than 15 | 10 (3.8%) | 11 (5.1%) | 21 (4.4%) | 0.58 |
15–19 | 124 (46.8%) | 90 (42.1%) | 214 (44.7%) | |
20–24 | 88 (33.2%) | 81 (37.9%) | 169 (35.3%) | |
25 and above | 43 (16.2%) | 32 (15.0%) | 75 (15.7%) | |
Number of children | 3.12 (1.97) | 2.62 (1.99) | 2.90 (1.99) | 0.006 |
Parity status | ||||
Nulliparous | 28 (10.5%) | 43 (19.7%) | 71 (14.7%) | 0.004 |
Parous | 238 (89.5%) | 175 (80.3%) | 413 (85.3%) | |
Abortion | ||||
No | 176 (66.2%) | 165 (75.7%) | 341 (70.5%) | 0.02 |
Yes | 90 (33.8%) | 53 (24.3%) | 143 (29.5%) | |
Ectopic pregnancy | ||||
No | 265 (99.6%) | 218 (100.0%) | 483 (99.8%) | 0.37 |
Yes | 1 (0.4%) | 0 (0.0%) | 1 (0.2%) | |
Age at menopause | 44.9 (5.44) | 45.8 (5.38) | 45.2 (5.40) | 0.49 |
Menopause | ||||
No | 199 (75.1%) | 176 (81.5%) | 375 (78.0%) | 0.09 |
Yes | 66 (24.9%) | 40 (18.5%) | 106 (22.0%) | |
Stillbirth | ||||
No | 253 (95.1%) | 212 (97.2%) | 465 (96.1%) | 0.23 |
Yes | 13 (4.9%) | 6 (2.8%) | 19 (3.9%) | |
Regular use of contraceptive methods | ||||
No | 143 (53.8%) | 141 (64.7%) | 284 (58.7%) | 0.02 |
Yes | 123 (46.2%) | 77 (35.3%) | 200 (41.3%) | |
Age at regular use of contraceptive methods | 28.3 (6.13) | 29.0 (5.98) | 28.6 (6.07) | 0.42 |
Duration of oral contraceptive use | ||||
Never used | 222 (83.5%) | 189 (86.7%) | 411 (84.9%) | 0.21 |
< 1 year | 21 (7.9%) | 19 (8.7%) | 40 (8.3%) | |
=/> 1 year | 23 (8.6%) | 10 (4.6%) | 33 (6.8%) | |
Duration of DMPA use | ||||
Never used | 212 (79.7%) | 200 (91.7%) | 412 (85.1%) | < 0.001 |
< 1 year | 20 (7.5%) | 5 (2.3%) | 25 (5.2%) | |
=/> 1 year | 34 (12.8%) | 13 (6.0%) | 47 (9.7%) | |
Duration of contraceptive implant use | ||||
Never used | 243 (91.4%) | 203 (93.1%) | 446 (92.1%) | 0.26 |
< 1 year | 10 (3.8%) | 3 (1.4%) | 13 (2.7%) | |
=/> 1 year | 13 (4.9%) | 12 (5.5%) | 25 (5.2%) | |
